$CME

CME Group Inc (CME) (Q3 2026) Earnings Call Highlights: Record Volumes and Revenue

CME Group reported record Q3 2026 results, with $100 billion in daily margin savings driven by increased activity across asset classes. Market data business grew 20%, with diverse demand sources. CEO Terry Duffy discussed legal and strategic updates, including the CFTC perpetuals lawsuit and 24/7 trading plans. New products like single stock futures and TreasuryLink saw strong adoption. CME emphasized disciplined capital allocation and pricing adjustments.

Original reporting
Published Oct 21, 2026, 11:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CME Group Inc (CME) (Q3 2026) Earnings Call Highlights: Record Volumes and Revenue — source image
Decision brief

The 30-second read

$CMEBullishMed
01

Why it matters

The disclosed margin savings and data growth signal robust earnings potential, likely supporting price appreciation.

02

Market read

CME's earnings beat expectations and new initiatives could drive short-term upside and influence the broader market infrastructure sector.

03

What to watch

Regulatory uncertainty around perpetuals and 24/7 contracts may pose execution risk.

Relevance 7/10Novelty 7/10Timing: post-earnings today

Background

CME Group's Q3 2026 earnings call highlighted record operational metrics and strategic product updates.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

Earnings call disclosed record $100B daily margin savings, 20% market data growth and new product launches, indicating strong revenue momentum.

Expected impact

likely upward pressure as investors price in higher margins and data revenue growth

Evidence & confidence

New quantitative metrics from the call are material and not previously public, supporting a bullish view.

Market effects

Strong data and margin performance may boost confidence in the broader exchange and clearing sector.

International demand for market data (over 50% outside the U.S.) highlights global exposure.

CME's 24/7 product discussions could influence other exchanges' strategies worldwide.

Counterpoint

Higher fees and pricing changes could dampen client activity, offsetting volume gains.

Key entities

  • CME Group Inc.

    US-listed exchange and clearinghouse.

Related articles

$CMEMed

CME Maintained by Barclays -- Price Target Raised to $321

Barclays maintained an Equal-Weight rating on CME Group (CME) but raised its price target to $321 from $281. CME's stock is currently priced at $305.65, which is 10.8% overvalued according to its GF Value™ of $275.98. The company has a GF Score™ of 88/100, indicating strong performance in profitability and growth. 19 gurus hold CME, with 12 adding to their positions recently.

$CMEMed

CME Maintained by Wells Fargo -- Price Target Raised to $333

Wells Fargo maintained an Overweight rating for CME Group and raised its price target to $333 from $315. CME operates the world's largest derivatives marketplace. GuruFocus values CME at $275.98, indicating a 10.9% overvaluation at its current price of $306.07. The company has a GF Score of 88, with strong growth and profitability metrics.

$CMEHigh

JPMorgan upgrades CME Group stock rating on rates outlook

JPMorgan upgraded CME Group (CME) from Underweight to Overweight, raising its price target to $367. The firm cited a supportive interest rate environment, higher trading velocity, and market uncertainty as favorable for CME. The stock currently trades at $295.79. CME reported stronger-than-expected Q3 2026 results, with adjusted EPS of $3.02 and revenue of $1.74 billion, up 13% YoY.

$CMEMed

CME Posts Record Q3 Revenue Despite Lower Daily Trading Volume

CME Group reported record Q3 revenue of $1.737bn, up 1.8% from Q2, despite a 1.3% drop in average daily volume. The increase was driven by two extra trading days and higher data service revenue. Clearing fees rose 1.9% to $1.378bn. CME launched new contracts but their impact on revenue is unclear. Fee changes in October could add 0.5%–1% to annual revenue.